The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes

by Philip J. Barter
Published 2011-04-01

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes

by Philip J. Barter
Published 2013-09-01

Production of plasma esterified cholesterol in lean, normotriglyceridemic humans

by Philip J. Barter
Published 1974-05-01

Origin of esterified cholesterol transported in the very low density lipoproteins of human plasma

by Philip J. Barter
Published 1974-01-01

The inhibition of cholesteryl ester transfer protein: a long and winding road1

by Kerry-Anne Rye, Philip J. Barter
Published 2012-06-01

Cardioprotective functions of HDLs1

by Kerry-Anne Rye, Philip J. Barter
Published 2014-02-01

Plasma free fatty acid transport during prolonged glucose consumption and its relationship to plasma triglyceride fatty acids in man

by Philip J. Barter, Paul J. Nestel
Published 1972-07-01

Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk

by Philip J. Barter, Kerry-Anne Rye
Published 2012-09-01

Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein

by Nongnuch Settasatian, Philip J. Barter, Kerry-Anne Rye
Published 2008-01-01

Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?1

by Philip J. Barter, Fatiha Tabet, Kerry-Anne Rye
Published 2015-11-01

Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E

by Kerry-Anne Rye, Richard Bright, Maria Psaltis, Philip J. Barter
Published 2006-05-01

Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein

by Kerry-Anne Rye, Matti Jauhiainen, Philip J. Barter, Christian Ehnholm
Published 1998-03-01

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

by Philip J. Barter, Gunnar Brandrup-Wognsen, Mike K. Palmer, Stephen J. Nicholls
Published 2010-06-01

Cholesteryl ester transfer protein and its inhibitors

by Sudichhya Shrestha, Ben J. Wu, Liam Guiney, Philip J. Barter, Kerry-Anne Rye
Published 2018-01-01

The metabolism and anti-atherogenic properties of HDL

by Kerry-Anne Rye, Christina A. Bursill, Gilles Lambert, Fatiha Tabet, Philip J. Barter
Published 2009-01-01

Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit

by Neil J. Hime, Kate J. Drew, Kevin Wee, Philip J. Barter, Kerry-Anne Rye
Published 2006-01-01

Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression

by Paul W. Baker, Kerry-Anne Rye, Jennifer R. Gamble, Mathew A. Vadas, Philip J. Barter
Published 2000-08-01

Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells

by Paul W. Baker, Kerry-Anne Rye, Jennifer R. Gamble, Mathew A. Vadas, Philip J. Barter
Published 1999-02-01

Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice.

by Rosanna W S Chung, Zeneng Wang, Christina A Bursill, Ben J Wu, Philip J Barter, Kerry-Anne Rye
Published 2017-01-01

The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004.

by Kwok-Leung Ong, Matthew A Allison, Bernard M Y Cheung, Ben J Wu, Philip J Barter, Kerry-Anne Rye
Published 2014-01-01